Assessing the in vitro biocompatibility of a novel carbon device for the treatment of sepsis.
The aim of the present study was to conduct a preliminary investigation into the blood biocompatibility of a novel, uncoated carbon for use in a filtration/adsorption device for the treatment of sepsis. Carbon well prototypes were manufactured from phenol-formaldehyde-aniline-based pyrolysed carbons using monolithic polymer technology. Inflammatory blood cell and plasma protein mediation of the inflammatory response were evaluated using the novel carbon prototypes and compared with dialyser membrane and tissue culture plate controls. Assays determining monocyte and granulocyte adhesion, platelet adhesion and activation, granulocyte activation and complement activation were performed. Preliminary findings suggest an adsorptive but passivating carbon surface. Moderate levels of monocyte and granulocytes adhesion were seen in conjunction with adsorption of plasma proteins to the carbon surface. Activation of granulocyte and adherent platelets was not detected and the complement cascade was not activated by the carbons, indicating a surface compatible with blood contact. The results support the further development of the proposed carbon-based device for the treatment of sepsis.
Sandeman
Susan R
SR
Biomedical Materials Research Group, School of Pharmacy and Biomolecular Sciences, University of Brighton, UK.
Howell
Carol A
CA
Phillips
Gary J
GJ
Lloyd
Andrew W
AW
Davies
J Graham
JG
Mikhalovsky
Sergey V
SV
Tennison
Steve R
SR
Rawlinson
Andrew P
AP
Kozynchenko
Oleksandr P
OP
Owen
Hannah L H
HL
Gaylor
John D S
JD
Rouse
Jennifer J
JJ
Courtney
James M
JM
D001672:Biocompatible Materials / Q000494:pharmacology* / Q000627:therapeutic use; D002244:Carbon / Q000494:pharmacology* / Q000627:therapeutic use*; D002478:Cells, Cultured; D003167:Complement Activation / Q000187:drug effects*; D006801:Humans; D008422:Materials Testing; D009000:Monocytes / Q000187:drug effects* / Q000276:immunology*; D015539:Platelet Activation / Q000187:drug effects*; D010973:Platelet Adhesiveness / Q000187:drug effects*; D006435:Renal Dialysis / Q000379:methods; D018805:Sepsis / Q000276:immunology / Q000628:therapy
D001672:Biocompatible Materials; D002244:Carbon